Plasma metabolites and inflammatory proteins profiling predict outcome of Fufang Duzhong Jiangu granules treating Kashin–Beck disease
Authors:
- 8 July 2024
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 38 (9) , e5945
Abstract
To investigate predictive biomarkers that could be used to identify patients’ response to treatment, plasma metabolomics and proteomics analyses were performed in Kashin–Beck disease (KBD) patients treated with Fufang Duzhong Jiangu Granules (FDJG). Plasma was collected from 12 KBD patients before treatment and 1 month after FDJG treatment. LC–MS and olink proteomics were employed for obtaining plasma metabolomics profiling and inflammatory protein profiles. Patients were classified into responders and non‐responders based on drug efficacy. Enrichment analyses of differential metabolites and proteins of the responders at baseline and after treatment were conducted to study the mechanism of drug action. Differential metabolites and proteins between the two groups were screened as biomarkers to predict the drug efficacy. The receiver operating characteristic curve was used to evaluate the prediction accuracy of biomarkers. The changes in metabolites and inflammatory proteins in responders after treatment reflected the mechanism of FDJG treatment for KBD, which may act on glycerophospholipid metabolism, d‐glutamine and d‐glutamate metabolism, nitrogen metabolism and NF‐kappa B signaling pathway. Three metabolites were identified as potential predictors: N‐undecanoylglycine, β‐aminopropionitrile and PC [18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)]. For inflammatory protein, interleukin‐8 was identified as a predictive biomarker to detect responders. Combined use of these four biomarkers had high predictive ability (area under the curve = 0.972).Keywords
All Related Versions
Funding Information
- National Key Research and Development Program of China (2022YFC2503100)
This publication has 37 references indexed in Scilit:
- The Prevalence of Kashin-Beck Disease in China: a Systematic Review and Meta-analysisBiological Trace Element Research, 2022
- Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platformsProteomics, 2022
- Extensive cytokine analysis in synovial fluid of osteoarthritis patientsCytokine, 2021
- Meta-analysis of Association Studies of Selenoprotein Gene Polymorphism and Kashin-Beck Disease: an Updated Systematic ReviewBiological Trace Element Research, 2021
- The effectiveness of treatments for Kashin–Beck disease: a systematic review and network meta-analysisClinical Rheumatology, 2019
- The Effect of β-Aminopropionitrile on Skeletal Micromorphology and OsteogenesisCalcified Tissue International, 2018
- Reliability and validation of the joint dysfunction index as a new assessment instrument for therapeutic efficacy for Kashin-Beck diseaseClinical Rheumatology, 2016
- Integrative analysis of genome-wide association studies and gene expression profiles identified candidate genes for osteoporosis in Kashin-Beck disease patientsOsteoporosis International, 2015
- Role of inflammation in the process of clinical Kashin-Beck disease: latest findings and interpretationsInflammation Research, 2015
- Growth‐related oncogene α induction of apoptosis in osteoarthritis chondrocytesArthritis & Rheumatism, 2002